The BLMK Medicines Optimisation Team

Updated Guidance for Continuous Glucose Monitors (CGM) in people with diabetes – Click Here

GLP-1 supply issues: please see the following:
NatPSA_2023_008_DHSC
GLP-1 RA National Shortage 2023 – FAQs
Further Information is available in the Primary Care Bulletin Tuesday 22nd August 2023

NEW DOCUMENT: BLMK Position Statements
NEW DOCUMENT: BLMK Antibiotics Guidance (this is an external link and will open in a new tab)
NEW DOCUMENT: BLMK ICB Gluten Free Foods Scheme: Participating Pharmacies
NEW DOCUMENT: BLMK ICB Hypertension Resources

Medicines Optimisation is a part of the wider medicines optimisation agenda. It is an evidence-based approach to prescribing which balances the safety, tolerability, effectiveness, cost and simplicity of treatments.

Good medicines optimisation means that patients receive better, safer and more convenient care. It focuses on the prescribing of medicines ensuring patients get the best use from their medicines, working closely with clinicians to ensure the NHS gets the best value.

The team are also involved in the access to high-risk and high-cost medicines and working with secondary and tertiary care, mental health and community services to ensure these medicines are prescribed appropriately and safely.